Evidence map›Paper›PMID 26656874›Full record

ArticleScientific reports2015

Identifying transcription start sites and active enhancer elements using BruUV-seq.

Brian Magnuson, Artur Veloso, Killeen S Kirkconnell, Leonardo Carmo de Andrade Lima, Michelle T Paulsen, Emily A Ljungman, Karan Bedi, Jayendra Prasad, Thomas E Wilson, Mats Ljungman

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. The Encyclopedia of DNA Elements.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Role of eRNAs in Cardiovascular Diseases.Current cardiology reviews · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Enhancer-derived RNA: A Primer.Genomics, proteomics & bioinformatics · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Brian MagnusonDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Artur VelosoDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Killeen S KirkconnellDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Leonardo Carmo de Andrade LimaDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Michelle T PaulsenDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Emily A LjungmanDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Karan BediDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Jayendra PrasadDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Thomas E WilsonDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Mats LjungmanDepartment of Radiation Oncology, University of Michigan Comprehensive Cancer Center and Translational Oncology Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
University of Michigan–Ann Arbor · USMichigan Center for Translational Pathology · USInstitute of Biomedical Science · GB

Funding

Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Translational Research in GI CancerP50CA130810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRENNER, DEAN E. · 2010 to 2016
$11.8M
PREDOCTORAL TRAINING IN GENETICST32GM007544 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1985 to 2022
$11.3M
ENVIRONMENTAL TOXICOLOGY PRE/POST DOCTORAL RES.TRAININGT32ES007062 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin Adam Colacino · 1985 to 2026
$10.5M
Development and Validation of BruChase-Seq and BrUV-SeqR01HG006786 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LJUNGMAN, MATS · 2012 to 2014
$1.1M
Mechanisms of Genotoxic Stress-regulated Gene Expression in Human CellsR21ES020946 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LJUNGMAN, MATS · 2012 to 2013
$424k
NCI NIH HHS P50 CA130810NCI NIH HHS P50CA130810NHGRI NIH HHS 1R01HG006786NHGRI NIH HHS R01 HG006786NIEHS NIH HHS 1R21ES020946NIEHS NIH HHS P30 ES017885NIEHS NIH HHS R21 ES020946NIEHS NIH HHS T32 ES007062NIEHS NIH HHS T32ES007062NIGMS NIH HHS T32 GM007544NIGMS NIH HHS T32GM07544
6 · The paper itself

Abstract

BruUV-seq utilizes UV light to introduce transcription-blocking DNA lesions randomly in the genome prior to bromouridine-labeling and deep sequencing of nascent RNA. By inhibiting transcription elongation, but not initiation, pre-treatment with UV light leads to a redistribution of transcription reads resulting in the enhancement of nascent RNA signal towards the 5'-end of genes promoting the identification of transcription start sites (TSSs). Furthermore, transcripts associated with arrested RNA polymerases are protected from 3'-5' degradation and thus, unstable transcripts such as putative enhancer RNA (eRNA) are dramatically increased. Validation of BruUV-seq against GRO-cap that identifies capped run-on transcripts showed that most BruUV-seq peaks overlapped with GRO-cap signal over both TSSs and enhancer elements. Finally, BruUV-seq identified putative enhancer elements induced by tumor necrosis factor (TNF) treatment concomitant with expression of nearby TNF-induced genes. Taken together, BruUV-seq is a powerful new approach for identifying TSSs and active enhancer elements genome-wide in intact cells.

Indexed as

Enhancer Elements, GeneticTranscription Initiation SiteUltraviolet RaysComputational BiologyDatabases, Nucleic AcidGene Expression RegulationGenome, HumanGenomicsHumansMolecular Sequence AnnotationTranscription Elongation, GeneticTranscription, Genetic

Identifiers

PMID26656874
PMCPMC4675984
OpenAlexW2294677910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.